ストックスクリーナーアプリを入手
1.40
1.44%
0.01
前日終値:
$1.39
開ける：
$1.39
24時間の取引高:
67,944
Relative Volume:
0.25
時価総額：
$130.91M
収益：
-
当期純損益:
$1.60M
株価収益率:
46.67
EPS:
0.03
ネットキャッシュフロー:
$-62.91M
1週間 パフォーマンス:
+4.44%
1か月 パフォーマンス:
-4.08%
6か月 パフォーマンス:
-1.40%
1年 パフォーマンス:
-18.97%
1日の値動き範囲:
$1.37
$1.425
1週間の範囲:
$1.29
$1.43
52週間の値動き範囲:
$1.13
$2.66
Compugen Ltd Stock (CGEN) Company Profile
CGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
1.40 | 123.44M | 0 | 1.60M | -62.91M | 0.03 |
|
ONC
Beigene Ltd Adr
|
236.22 | 25.21B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.88 | 112.83B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.285 | 40.72M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
611.14 | 62.15B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
74.30 | 5.75B | 0 | -153.72M | -103.81M | -2.00 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-13 | 開始されました | Oppenheimer | Outperform |
| 2022-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2020-05-26 | 再開されました | JMP Securities | Mkt Outperform |
| 2020-05-13 | 開始されました | Stifel | Buy |
| 2020-05-07 | 開始されました | SVB Leerink | Outperform |
| 2020-04-22 | 開始されました | ROTH Capital | Buy |
| 2020-03-24 | 開始されました | SunTrust | Buy |
| 2020-01-16 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-03-29 | 開始されました | Oppenheimer | Outperform |
| 2016-02-01 | 再開されました | Oppenheimer | Outperform |
| 2015-10-15 | 開始されました | FBR Capital | Outperform |
| 2015-04-23 | 再開されました | Jefferies | Buy |
| 2015-04-21 | 開始されました | Oppenheimer | Outperform |
| 2014-02-07 | 開始されました | MLV & Co | Buy |
| 2009-12-28 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2009-07-29 | 開始されました | Cantor Fitzgerald | Buy |
すべてを表示
Compugen Ltd (CGEN) 最新ニュース
Compugen Ltd. (NASDAQ:CGEN) Q1 2025 Earnings Call Transcript - Insider Monkey
Compugen Ltd (CGEN) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Decline - Yahoo Finance
Compugen’s Q1 2025: Clinical Progress and Financial Stability - TipRanks
Compugen: Q1 Earnings Snapshot - MySA
Compugen earnings missed, revenue fell short of estimates By Investing.com - Investing.com India
Compugen Q1 2025 Earnings Call Transcript - MarketBeat
Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Transcript : Compugen Ltd., Q1 2025 Earnings Call, May 19, 2025 - marketscreener.com
Compugen Ltd reports results for the quarter ended March 31Earnings Summary - TradingView
Compugen earnings missed, revenue fell short of estimates - Investing.com Australia
Compugen Reports First Quarter 2025 Results | CGEN Stock News - GuruFocus
Compugen Reports First Quarter 2025 Results - Yahoo Finance
Compugen (CGEN) to Release Earnings on Monday - Defense World
COMPUGEN Earnings Preview: Recent $CGEN Insider Trading, Hedge Fund Activity, and More - Nasdaq
Compugen CEO Anat Cohen-Dayag to transition to executive chair - MSN
Raymond James Financial Inc. Acquires Shares of 67,041 Compugen Ltd. (NASDAQ:CGEN) - Defense World
Compugen (CGEN) Announces Leadership Transition for 2025 | CGEN Stock News - GuruFocus
Compugen Announces Leadership Transitions Effective September 20 - GuruFocus
Compugen Announces Leadership Transitions Effective September 2025 - marketscreener.com
Compugen Announces Leadership Changes Effective September 2025 - TipRanks
Compugen announces executive leadership changes By Investing.com - Investing.com India
Compugen announces executive leadership changes - Investing.com
Compugen Ltd. Announces Chief Executive Officer Changes - marketscreener.com
Investor Network: Compugen Ltd. to Host Earnings Call - ACCESS Newswire
Compugen to Release First Quarter 2025 Results on Monday, May 19, 2025 | CGEN Stock News - GuruFocus
Compugen to Release First Quarter 2025 Results on Monday, May 19, 2025 - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
67,041 Shares in Compugen Ltd. (NASDAQ:CGEN) Acquired by Raymond James Financial Inc. - Defense World
Compugen (NASDAQ:CGEN) vs. Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) Financial Review - Defense World
Commonwealth Equity Services LLC Takes Position in Compugen Ltd. (NASDAQ:CGEN) - Defense World
Compugen Ltd. Announces Appointment of Alberto Sessa as Chief Financial Officer - marketscreener.com
Compugen at Stifel Forum: Strategic Insights on Immunotherapy Pipeline By Investing.com - Investing.com South Africa
Compugen at Stifel Forum: Strategic Insights on Immunotherapy Pipeline - Investing.com Australia
Is There An Opportunity With Compugen Ltd.'s (NASDAQ:CGEN) 33% Undervaluation? - simplywall.st
Compugen at Needham Conference: Strategic Immuno-Oncology Insights - Investing.com Australia
Compugen at Needham Conference: Strategic Immuno-Oncology Insights By Investing.com - Investing.com India
Compugen stock touches 52-week low at $1.35 amid market challenges - Investing.com Canada
Compugen stock touches 52-week low at $1.35 amid market challenges By Investing.com - Investing.com South Africa
BeiGene stock slips on trial discontinuation (ONC:NASDAQ) - Seeking Alpha
Compugen at AI Drug Discovery Conference: Strategic Partnerships Drive Progress - Investing.com
Cancer AI Breakthrough: Compugen Takes Center Stage at 3 Elite Healthcare Forums - Stock Titan
Compugen Ltd. (CGEN): Among the Penny Stocks With Huge Upside Potential According to Analysts - MSN
Compugen Ltd. (NASDAQ:CGEN) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - Defense World
Reviewing Aligos Therapeutics (NASDAQ:ALGS) and Compugen (NASDAQ:CGEN) - Armenian Reporter
Compugen at Leerink’s Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com South Africa
Compugen at Leerink’s Global Healthcare Conference: Strategic Insights - Investing.com
Oppenheimer & Co. Inc. Raises Stock Position in Compugen Ltd. (NASDAQ:CGEN) - Defense World
Compugen Ltd (CGEN) 財務データ
収益
当期純利益
現金流量
EPS
0.78%
1.61%
大文字化:
|
ボリューム (24 時間):